Çocuk Yogun Bakım Ünitesinde Yatan Hastalarda Serum Fosfor Düzeyinin Morbidite ve Mortalite Üzerine Etkisi


Tezin Türü: Tıpta Uzmanlık

Tezin Yürütüldüğü Kurum: Sağlık Bilimleri Üniversitesi, Ankara Dr. Sami Ulus Kadın Doğum Çocuk Sağlığı Ve Hastalıkları Sağlık Uygulama Ve Araştırma Merkezi, Dahili Tıp Bilimleri Bölümü, Türkiye

Tezin Onay Tarihi: 2012

Tezin Dili: Türkçe

Öğrenci: Yılmaz Akbaş

Asıl Danışman (Eş Danışmanlı Tezler İçin): Nilgün Erkek

Özet:

Objective

Hypophosphatemia was previously shown to affect the duration of admission, mechanical ventilator requirements, mortality and morbidity during pediatric intensive care. Different from previous studies, our study was planned with the aim of showing whether hyperphosphatemia affects morbidity and mortality in pediatric intensive care patients as much as hypophosphatemia.

Method

Patients' ages, genders, reason for admission, underlying diseases, phosphorus levels examined on admission and on the 1-4th and 5-10th-days, duration on mechanical ventilation, duration of admission, final status and PRISM and PELOD scores calculated in the first 24 hours of admission were recorded.

Results

Mortality was distinctly higher for those who were hypophosphatemic and hyperphosphatemic compared to those who were normophosphatemic. The highest mortality was identified in those who were hyperphosphatemic on the 5-10th-days. PELOD scores were only significantly different according to admission phosphorus levels (p:0.04).

Conclusion

In our study, we identified that hyperphosphatemia is a serious problem as hypophosphatemia for patients who admitted to the PICU. Patients identified to be hyperphosphatemic on admission had a significantly higher PELOD score. The significant difference of hyperphosphatemia in terms of PELOD score is one of the important points shown in our study. It should not be forgotten that like hypophosphatemia, hyperphosphatemia may cause serious problems in pediatric intensive care patients.